When Will New COVID-19 Antivirals Be Approved in the U.S.?
When a young, healthy person in the U.S. catches COVID-19, there’s not much they can do except stay home and rest. The antiviral drug Paxlovid is widely available, but it’s only approved for people at high risk of severe disease, such as older adults and people with underlying conditions. The U.S. Food and Drug Administration (FDA) hasn’t approved any drugs that can treat COVID-19 among people who are unlikely to get very sick or die, but nonetheless would like some relief from their symptoms.These drugs do exist, though. Antivirals currently available overseas seem to be effective at shortening the length and treating the symptoms of mild-to-moderate cases of COVID-19—but it’s anyone’s guess if and when they’ll make the jump to the U.S. market.A study published in the New England Journal ...










